Sfoglia per AUTORE
ZAJA F
Collezione AOU Novara

  

Items : 20

Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana Linfomi. in British journal of haematology / Br J Haematol. 2024 Jun 28. doi: 10.1111/bjh.19617.

2024
AOU Città della Salute di Torino
AOU Novara

Dodero A; Gaidano G; Fabbri A; Olivieri J; Arcaini L; Tani M; Zilioli VR; Visco C; Castiglione A; Re A; Lucchini E; Clerico M; Cavallo F; Zaja F;

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2023 Mar 10;13:1120967. doi: 10.3389/fonc.2023.1120967. eCollection 2023.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Fama A; Zaja F; Olivieri J; Rotondo F; Cenfra N; Ciavarella S; Kovalchuk S; Castellino A; Cattina F; Boccomini C; Bozzoli V; Annibali O; Nicolosi M; Petrucci L; Cocito F; Meli E; Bigliardi S; Margiotta-Casaluci G;

Genetic and phenotypic attributes of splenic marginal zone lymphoma. in Blood / Blood. 2022 Feb 3;139(5):732-747. doi: 10.1182/blood.2021012386.

2022
AO Cuneo
AOU Novara
AO Alessandria

Rossi D; Ponzoni M; Mazzucchelli L; Zucca E; Cavalli F; Paulli M; Piris MA; Traverse-Glehen A; Tzankov A; Campo E; Pileri SA; Dirnhofer S; De Leval L; Bhagat G; Bertoni F; Zinzani PL; Khiabanian H; Zaja F; Calcinotto A; Zenz T; Vitolo U; Visco C; Walewska R; Vanini G; Tousseyn T; Tucci A; Tarella C; Thieblemont C; Tapia G; et alii...

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4504-4514. doi: 10.1182/bloodadvances.2021005150.

2021
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Filippi AR; Freilone R; Ciccone G; Rota-Scalabrini D; Zilioli VR; Botto B; Abruzzese E; Zaja F; Tani M; Rigacci L; Santoro A; Simontacchi G; Grapulin L; Pulsoni A; Zanni M; Franzone P; Nassi L; Frezza GP; Nardella A; Re A; Buglione M; Pavone V; Gioia DM; Sacchetti GM; Gotti M; Evangelista A; Levis M; Ricardi U; Zinzani PL; et alii...

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.

2021
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Pagano L; Corradini P; Bertù L; Petrucci L; Zaja F; Grossi PA; Musto P; Visani G; Lanza F; Cattaneo C; La Barbera EO; Mina R; Cardinali V; Galimberti S; Luppi M; Krampera M; Fracchiolla N; Bocchia M; Candoni A; Armiento D; Arcaini L; Tafuri A; Busca A; Marchesi F; Pinto A; Massaia M; Ladetto M; Venditti A; Cairoli R; et alii...

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia. in The New England journal of medicine / N Engl J Med. 2021 May 13;384(19):1810-1823. doi: 10.1056/NEJMoa2031298.

2021
AOU Novara

Tiacci E; De Carolis L; Simonetti E; Capponi M; Ambrosetti A; Lucia E; Antolino A; Pulsoni A; Ferrari S; Zinzani PL; Ascani S; Perriello VM; Rigacci L; Gaidano G; Della Seta R; Frattarelli N; Falcucci P; Foà R; Visani G; Zaja F; Falini B;

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study. in Haematologica / Haematologica. 2021 Feb 1;106(2):622-625. doi: 10.3324/haematol.2020.250522.

2021
AOU Novara

Hill A; Patriarca A; Zaja F; Jilma B; Mauro FR; Vos JMI; Frederiksen H; Guillet S; Giannotta J; Zaninoni A; Michel M; Fattizzo B; Berentsen S; Barcellini W;

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino
AOU Novara

Vianelli N; Zaja F; De Stefano V; Rodeghiero F; Mazzucconi MG; Cavo M; Sutto E; Carpenedo M; Carli G; Nicolosi D; Baldacci E; Auteri G; Borchiellini A; Giuffrida G; Caocci G; Chiurazzi F; Consoli U; Cantoni S; Oliva EN; Barcellini W; Patriarca A; Rivolti E; Carrai V; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Palandri F; Rossi E; et alii...

Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. in British journal of haematology / Br J Haematol. 2021 Apr;193(2):386-396. doi: 10.1111/bjh.17334. Epub 2021 Feb 22.

2021
AOU Città della Salute di Torino
AOU Novara

Zaja F; Fanin R; Rodeghiero F; Carpenedo M; Giardini I; Gigliotti CL; Boggio E; Dianzani U; Crea E; Vignetti M; Paoloni F; Santoro C; Barcellini W; Celli M; Consoli U; Valeri F; Carli G; Patriarca A; Rossi E; Auteri G; Vianelli N; Volpetti S; Palandri F; Lucchini E;

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2021 Dec 6;11:789891. doi: 10.3389/fonc.2021.789891. eCollection 2021.

2021
AOU Novara

Re A; Merli M; Tisi MC; Lucchini E; Corradini P; Luminari S; Volpetti S; Tabanelli V; Casadei B; Tani M; Bruna R; Pileri S; Zinzani PL; Ballotta L; Varettoni M; Pesce EA; Zaja F;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.

2020
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; Forconi F; Mauro FR; Giudice ID; Peroni D; Kodipad AA; Jabangwe C; Sagiraju S; et alii...

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL). in HemaSphere / Hemasphere. 2019 Oct 22;3(6):e305. doi: 10.1097/HS9.0000000000000305. eCollection 2019 Dec.

2019
ASL Torino 4
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Zaja F; Visco C; Loseto G; Mazzone AM; Olivieri J; Nassi L; Piazza F; Fama A; Giannoccaro M; Greco A; Di Rocco A; Tomei G; Sgherza N; Mansueto G; Gini G; Mosna F; Finolezzi E; Calimeri T; Di Napoli A; Zanni M; Zilioli VR; Flenghi L; Romano A; Pelosini M; Marino D; Balzarotti M; Rattotti S; Stefani PM; Novo M; et alii...

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Dec;59(12):2904-2910. doi: 10.1080/10428194.2018.1452208. Epub 2018 Apr 4.

2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Levis A; Fanin R; Bushell K; Morin R; Alcaide M; Mann KK; Assouline S; Volpetti S; Perali G; Cavallo F; Piccaluga PP; Lenti V; Patti C; Pileri SA; Tucci A; Califano C; Zinzani PL; Chiappella A; Vitolo U; Zanni M; Ladetto M; Gaidano G; Angelucci E; Ciccone G; Evangelista A; Sabattini E; Rossi M; Zaja F; Salvi F; et alii...

Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography. in Annals of hematology / Ann Hematol. 2017 Jul;96(7):1147-1153. doi: 10.1007/s00277-017-2996-8. Epub 2017 Apr 28.

2017
AOU Città della Salute di Torino
AOU Novara

Falorio S; Zanon S; Filì C; Finolezzi E; Guariglia R; Sassone MC; Toldo C; Mulè A; Di Rocco A; Riccomagno PC; Ciancia R; Volpetti S; Minoia C; Puccini B; Nassi L; Furlan A; Doa G; Zaja F;

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. in The Lancet. Oncology / Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.

2017
AOU Città della Salute di Torino
AOU Novara

Tucci A; Cabras MG; Congiu AG; Gotti M; Castellino A; Russo E; Cascavilla N; D'Arco A; Zaja F; Rigacci L; Pavone V; Gaidano G; Merli F; Balzarotti M; Rossi G; Stelitano C; Carella AM; Evangelista A; Brusamolino E; Angelucci E; Martelli M; Chiappella A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U;

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16.

2016
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Levis A; Argnani L; Sacchetti GM; Borsatti E; Pregno P; Freilone R; Tani M; Rusconi C; Salvi F; Stelitano C; Gaidano G; Rigacci L; Pulsoni A; Pavone V; Vitolo U; Zaja F; Anastasia A; Rossi G; Brusamolino E; Bonfichi M; Ricardi U; Santoro A; Evangelista A; Ciccone G; Castagnoli A; Gioia DM; Broccoli A; Zinzani PL;

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. in The New England journal of medicine / N Engl J Med. 2015 Oct 29;373(18):1733-47. doi: 10.1056/NEJMoa1506583. Epub 2015 Sep 9.

2015
AOU Novara

Tiacci E; Park JH; De Carolis L; Chung SS; Broccoli A; Scott S; Zaja F; Devlin S; Pulsoni A; Chung YR; Cimminiello M; Kim E; Rossi D; Stone RM; Motta G; Saven A; Varettoni M; Altman JK; Anastasia A; Grever MR; Ambrosetti A; Rai KR; Fraticelli V; Lacouture ME; Carella AM; Levine RL; Leoni P; Rambaldi A; Falzetti F; et alii...

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AOU Città della Salute di Torino
AOU Novara

Zinzani PL; Massaia M; Moreno C; Del Poeta G; Perbellini O; Marasca R; Neri A; Tedeschi A; Rigolin GM; Motta M; Coscia M; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Cortelezzi A; Mauro FR; Morabito F; Visco C; Bulian P; Chiarenza A; Ghilardi G; Cerri M; De Paoli L; Terzi-di-Bergamo L; Rossi D; Montillo M; et alii...

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia. in Leukemia & lymphoma / Leuk Lymphoma. 2015;56(9):2637-42. doi: 10.3109/10428194.2015.1012714. Epub 2015 Mar 14.

2015
AOU Città della Salute di Torino
AOU Novara

Frustaci AM; Orsucci L; Ghione P; Urbano MA; Franceschetti S; Gentile M; Ravelli E; Belsito Petrizi V; Zaja F; Visco C; Goldaniga MC; Gini G; Motta M; Varettoni M; Baratè C; Margiotta Casaluci G; Ferrero S; Benevolo G; Picardi P; Tedeschi A; Gaidano G; Vitolo U; Morra E;

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.

2014
AOU Città della Salute di Torino
AOU Novara

Neri A; Piciocchi A; Vignetti M; Morabito F; Fabris S; Mauro FR; Gobbi M; Cascavilla N; Angelucci E; Storti S; Orsucci L; Gritti G; Chiarenza A; Marasca R; Zaja F; Laurenti L; Reda G; Cuneo A; Vincenti D; Liberati AM; Sciumè M; Cortelezzi A; Rossi D; Giannarelli D; Guarini A; Foà R;